ANXA1 and colorectal carcinoma: Our previous studies have revealed that CA1 is expressed at low levels and ANXA1 is highly expressed in clinical TNM stages I-IV by MALDI-TOF/TOF MS and immunohistochemical analyses of 103 CRC samples from Chinese patients [16].